Pengxiang Li

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. doi request reprint Role of multihospital system membership in electronic medical record adoption
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
    Health Care Manage Rev 33:169-77. 2008
  2. pmc Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006
    Pengxiang Li
    Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    J Am Heart Assoc 5:. 2016
  3. doi request reprint Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia
    Pengxiang Li
    University of Pennsylvania, Philadelphia, PA 19104, USA
    Ann Intern Med 156:776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. 2012
  4. doi request reprint Factors associated with Iowa rural hospitals' decision to convert to critical access hospital status
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Rural Health 25:70-6. 2009
  5. ncbi request reprint Converting to critical access status: how does it affect rural hospitals' financial performance?
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, 19104, USA
    Inquiry 46:46-57. 2009
  6. pmc Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    BMC Health Serv Res 10:245. 2010
  7. pmc Effect of critical access hospital conversion on patient safety
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, 1215 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA
    Health Serv Res 42:2089-108; discussion 2294-323. 2007
  8. doi request reprint Specialty Tier-Level Cost Sharing and Biologic Agent Use in the Medicare Part D Initial Coverage Period Among Beneficiaries With Rheumatoid Arthritis
    Jalpa A Doshi
    University of Pennsylvania, Philadelphia
    Arthritis Care Res (Hoboken) 68:1624-1630. 2016
  9. ncbi request reprint High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia
    Jalpa A Doshi
    University of Pennsylvania, 1223 Blockley Hall, Philadelphia, PA 19104 E mail
    Am J Manag Care 22:s78-86. 2016
  10. pmc Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012
    Pengxiang Li
    Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
    PLoS ONE 11:e0154357. 2016

Detail Information

Publications14

  1. doi request reprint Role of multihospital system membership in electronic medical record adoption
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
    Health Care Manage Rev 33:169-77. 2008
    ..Nevertheless, substantial variation currently exists in the adoption of electronic medical records (EMRs) resulting in differences in hospital HIT capacity...
  2. pmc Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006
    Pengxiang Li
    Division of General Internal Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
    J Am Heart Assoc 5:. 2016
    ..This study aimed to examine the impact of increases in patient cost-sharing differentials for brand name and generic drugs on statin utilization on entry into the Medicare Part D coverage gap...
  3. doi request reprint Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia
    Pengxiang Li
    University of Pennsylvania, Philadelphia, PA 19104, USA
    Ann Intern Med 156:776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. 2012
    ..Prior studies of the Medicare Part D coverage gap are limited in generalizability and scope...
  4. doi request reprint Factors associated with Iowa rural hospitals' decision to convert to critical access hospital status
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Rural Health 25:70-6. 2009
    ..Some subsequent CAH-related laws reduced restrictions and increased payments, and the number of CAHs grew rapidly...
  5. ncbi request reprint Converting to critical access status: how does it affect rural hospitals' financial performance?
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, 19104, USA
    Inquiry 46:46-57. 2009
    ..We found that rural hospital CAH conversion was associated with significant increases in hospital operating revenues, expenses, and margins...
  6. pmc Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortality
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    BMC Health Serv Res 10:245. 2010
    ..This study intends to assess the performance of the CMS-HCC risk adjustment method and to compare it to the Charlson and Elixhauser comorbidity measures in predicting in-hospital and six-month mortality in Medicare beneficiaries...
  7. pmc Effect of critical access hospital conversion on patient safety
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, 1215 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA
    Health Serv Res 42:2089-108; discussion 2294-323. 2007
    ....
  8. doi request reprint Specialty Tier-Level Cost Sharing and Biologic Agent Use in the Medicare Part D Initial Coverage Period Among Beneficiaries With Rheumatoid Arthritis
    Jalpa A Doshi
    University of Pennsylvania, Philadelphia
    Arthritis Care Res (Hoboken) 68:1624-1630. 2016
    ..To examine associations between specialty tier-level cost sharing and use of biologic agents for rheumatoid arthritis (RA) during Medicare Part D's initial coverage period (ICP)...
  9. ncbi request reprint High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia
    Jalpa A Doshi
    University of Pennsylvania, 1223 Blockley Hall, Philadelphia, PA 19104 E mail
    Am J Manag Care 22:s78-86. 2016
    ..Oral tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML), making it an apt case study...
  10. pmc Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012
    Pengxiang Li
    Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
    PLoS ONE 11:e0154357. 2016
    ....
  11. pmc Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    Cancer Med 5:169-81. 2016
    ..Future studies should examine the real-world survival improvements directly associated with targeted therapies. ..
  12. ncbi request reprint Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions
    Jalpa A Doshi
    Center for Evidence Based Practice, Director, Value based Insurance Design Initiatives, Center for Health Incentives and Behavioral Economics, University of Pennsylvania, 1223 Blockley Hall, Philadelphia, PA 19104 E mail
    Am J Manag Care 22:188-97. 2016
    ....
  13. pmc Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritis
    Jalpa A Doshi
    University of Pennsylvania School of Medicine and Leonard Davis Institute of Health Economics, Philadelphia, PA 19104 6021, USA
    Arthritis Care Res (Hoboken) 62:354-61. 2010
    ....
  14. doi request reprint Adherence, discontinuation, and switching of biologic therapies in medicaid enrollees with rheumatoid arthritis
    Pengxiang Li
    Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Value Health 13:805-12. 2010
    ..This study examined adherence, discontinuation, and switching of rheumatoid arthritis (RA) biologics over a 1-year period after initiation of the biologic treatment in Medicaid patients with RA...